These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 27909869)

  • 1. Effect of Oral ω3-Polyunsaturated Fatty Acids as a Complement Management to Control Fistula Output and Inflammation in Patients With Digestive Fistula.
    Martínez-Ordaz JL; Boscó-Gárate I; Cérbulo-Vázquez A; Arriaga-Pizano L; Wong-Baeza I; Sánchez-Fernandez P; López-Macías C; Isibasi A; Ferat-Osorio E
    J Gastrointest Surg; 2017 Mar; 21(3):453-462. PubMed ID: 27909869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials.
    Martins JG
    J Am Coll Nutr; 2009 Oct; 28(5):525-42. PubMed ID: 20439549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EPA, not DHA, prevents fibrosis in pressure overload-induced heart failure: potential role of free fatty acid receptor 4.
    Eclov JA; Qian Q; Redetzke R; Chen Q; Wu SC; Healy CL; Ortmeier SB; Harmon E; Shearer GC; O'Connell TD
    J Lipid Res; 2015 Dec; 56(12):2297-308. PubMed ID: 26435012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between Ω3 and Ω6 fatty acid intakes and serum inflammatory markers in COPD.
    de Batlle J; Sauleda J; Balcells E; Gómez FP; Méndez M; Rodriguez E; Barreiro E; Ferrer JJ; Romieu I; Gea J; Antó JM; Garcia-Aymerich J;
    J Nutr Biochem; 2012 Jul; 23(7):817-21. PubMed ID: 21889886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, crossover, head-to-head comparison of eicosapentaenoic acid and docosahexaenoic acid supplementation to reduce inflammation markers in men and women: the Comparing EPA to DHA (ComparED) Study.
    Allaire J; Couture P; Leclerc M; Charest A; Marin J; Lépine MC; Talbot D; Tchernof A; Lamarche B
    Am J Clin Nutr; 2016 Aug; 104(2):280-7. PubMed ID: 27281302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ω6/ω3 Polyunsaturated fatty acid supplementations in renal cell model lead to a particular regulation through lipidome for preserved ω6/ω3 ratios.
    Fares M; Armand M; Francois C; Maixent JM
    Cell Mol Biol (Noisy-le-grand); 2012 Jun; 58 Suppl():OL1715-9. PubMed ID: 22762527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omega-3 fatty acids protect retinal neurons in the DBA/2J hereditary glaucoma mouse model.
    Kalogerou M; Kolovos P; Prokopiou E; Papagregoriou G; Deltas C; Malas S; Georgiou T
    Exp Eye Res; 2018 Feb; 167():128-139. PubMed ID: 29258748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Red blood cell fatty acid analysis for determining compliance with omega3 supplements in dry eye disease trials.
    Gadaria-Rathod N; Dentone PG; Peskin E; Maguire MG; Moser A; Asbell PA
    J Ocul Pharmacol Ther; 2013 Nov; 29(9):837-41. PubMed ID: 23971620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of long-term vitamin D and n-3 fatty acid supplementation on inflammatory and cardiac biomarkers in patients with type 2 diabetes: secondary analyses from a randomised controlled trial.
    Limonte CP; Zelnick LR; Ruzinski J; Hoofnagle AN; Thadhani R; Melamed ML; Lee IM; Buring JE; Sesso HD; Manson JE; de Boer IH
    Diabetologia; 2021 Feb; 64(2):437-447. PubMed ID: 33098434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omega-3 fatty acids promote neuroprotection, decreased apoptosis and reduced glial cell activation in the retina of a mouse model of OPA1-related autosomal dominant optic atrophy.
    Kalogerou M; Ioannou S; Kolovos P; Prokopiou E; Potamiti L; Kyriacou K; Panagiotidis M; Ioannou M; Fella E; Worth EP; Georgiou T
    Exp Eye Res; 2022 Feb; 215():108901. PubMed ID: 34933001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fish oil decreases C-reactive protein/albumin ratio improving nutritional prognosis and plasma fatty acid profile in colorectal cancer patients.
    Mocellin MC; Pastore e Silva Jde A; Camargo Cde Q; Fabre ME; Gevaerd S; Naliwaiko K; Moreno YM; Nunes EA; Trindade EB
    Lipids; 2013 Sep; 48(9):879-88. PubMed ID: 23888317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential therapeutic impact of omega-3 long chain-polyunsaturated fatty acids on inflammation markers in Duchenne muscular dystrophy: A double-blind, controlled randomized trial.
    Rodríguez-Cruz M; Cruz-Guzmán ODR; Almeida-Becerril T; Solís-Serna AD; Atilano-Miguel S; Sánchez-González JR; Barbosa-Cortés L; Ruíz-Cruz ED; Huicochea JC; Cárdenas-Conejo A; Escobar-Cedillo RE; Yam-Ontiveros CA; Ricárdez-Marcial EF
    Clin Nutr; 2018 Dec; 37(6 Pt A):1840-1851. PubMed ID: 28987470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of supplemental long-chain omega-3 fatty acids and erythrocyte membrane fatty acid content on circulating inflammatory markers in a randomized controlled trial of healthy adults.
    Flock MR; Skulas-Ray AC; Harris WS; Gaugler TL; Fleming JA; Kris-Etherton PM
    Prostaglandins Leukot Essent Fatty Acids; 2014 Oct; 91(4):161-8. PubMed ID: 25091379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eicosapentaenoic acid and docosapentaenoic acid monoglycerides are more potent than docosahexaenoic acid monoglyceride to resolve inflammation in a rheumatoid arthritis model.
    Morin C; Blier PU; Fortin S
    Arthritis Res Ther; 2015 May; 17():142. PubMed ID: 26022389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diet Supplementation in ω3 Polyunsaturated Fatty Acid Favors an Anti-Inflammatory Basal Environment in Mouse Adipose Tissue.
    Colson C; Ghandour RA; Dufies O; Rekima S; Loubat A; Munro P; Boyer L; Pisani DF
    Nutrients; 2019 Feb; 11(2):. PubMed ID: 30791540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of ω3 long-chain polyunsaturated fatty acids in reducing cardio-metabolic risk factors.
    Abeywardena MY; Patten GS
    Endocr Metab Immune Disord Drug Targets; 2011 Sep; 11(3):232-46. PubMed ID: 21831036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of change in omega-3 index with fish oil supplementation in peripheral artery disease.
    Drudi LM; Schaller MS; Hiramoto J; Gasper W; Harris WS; Hills NK; Grenon SM
    J Surg Res; 2017 Apr; 210():124-131. PubMed ID: 28457318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of omega-3 fatty acid supplementation on arterial elasticity in patients with familial hypercholesterolaemia on statin therapy.
    Chan DC; Pang J; Barrett PH; Sullivan DR; Mori TA; Burnett JR; van Bockxmeer FM; Watts GF
    Nutr Metab Cardiovasc Dis; 2016 Dec; 26(12):1140-1145. PubMed ID: 27614801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fish oil supplementation does not lower C-reactive protein or interleukin-6 levels in healthy adults.
    Muldoon MF; Laderian B; Kuan DC; Sereika SM; Marsland AL; Manuck SB
    J Intern Med; 2016 Jan; 279(1):98-109. PubMed ID: 26497831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fish oil supplementation fails to modulate indices of muscle damage and muscle repair during acute recovery from eccentric exercise in trained young males.
    Mackay J; Bowles E; Macgregor LJ; Prokopidis K; Campbell C; Barber E; Galloway SDR; Witard OC
    Eur J Sport Sci; 2023 Aug; 23(8):1666-1676. PubMed ID: 37010103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.